HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides.

Abstract
Nitazoxanide, the first thiazolide, was originally developed for the treatment of Cryptosporidium parvum. More recently, antiviral activity of nitazoxanide against hepatitis B virus (HBV) and hepatitis C virus was recognized in in vitro systems. These basic studies led to phase II clinical trials that demonstrated the safety and efficacy of nitazoxanide in combination with peginterferon, with or without ribavirin, in the treatment of chronic hepatitis C genotype 4. The sustained virologic response rate was 79% and 80% in two studies, which was higher than the response rate of 50% with the standard of care with peginterferon plus ribavirin. In very preliminary studies of patients with chronic hepatitis B, nitazoxanide suppressed serum HBV DNA and led to loss of hepatitis B e antigen in the majority of patients and hepatitis B surface antigen in approximately a quarter of patients. Randomized controlled studies of naive and nonresponder patients with chronic hepatitis C genotype 1 are underway, new second generation and controlled release thiazolides are being developed, and future studies of patients with chronic hepatitis B are planned.
AuthorsEmmet B Keeffe, Jean-François Rossignol
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 15 Issue 15 Pg. 1805-8 (Apr 21 2009) ISSN: 2219-2840 [Electronic] United States
PMID19370775 (Publication Type: Journal Article)
Chemical References
  • Antiparasitic Agents
  • Antiviral Agents
  • Nitro Compounds
  • Placebos
  • Thiazoles
  • nitazoxanide
Topics
  • Antiparasitic Agents (therapeutic use)
  • Antiviral Agents (therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Hepatitis B, Chronic (drug therapy)
  • Hepatitis C, Chronic (drug therapy)
  • Humans
  • Nitro Compounds
  • Placebos
  • Thiazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: